Search

You searched for "treatment"

810 results found
European Urology journal cover image.

Call for standardised reporting of adverse events

27 January 2021 | | URO - Urologic Oncology
This article will be of immense benefit to all of us involved in mortality and morbidity meetings and Clinical Governance, especially registrars and junior members of the team. The authors present data from the UK, USA and Europe. In prostate...
The Journal of Urology cover image.

Upper tract urothelial carcinoma following cystectomy

3 May 2022 | | URO - Urologic Oncology
Metachronous upper tract urothelial cancer (UTUC) is encountered in about 5% of patients after radical cystectomy (RC) with a median time to diagnosis of 24-36 months after RC, and most are asymptomatic and detected by surveillance protocols. In this multivariate...
The Journal of Urology cover image.

Botox® instillation into the bladder

4 May 2023 | | URO - Basic Science Research, URO - Functional / Reconstructive Urology, URO - Infection, URO - Neurourology
Patients with refractory overactive bladder (OAB) may be offered OnabotulinumtoxinA (Botox®) as one of the third-line options. Given the invasive nature of requiring cystoscopy, injections via a needle and local anaesthesia, it would be simpler, more convenient and more accessible...

SNNLive caught up with Andrew Tasker, CEO of Femeda Ltd.

7 June 2019 | Research & Development
SNNLive spoke with Andrew Tasker, CEO of Femeda Ltd. at the Planet MicroCap Showcase 2019 in Las Vegas, NV, and they discuss the following topics: Overview and history of Femeda, Update since our last interview...

Our experience: from London and Glasgow urology, to the world down under

4 July 2024 | | URO - Core Urology
In November 2023, we were privileged to have been hosted at the Urological Society of Australia and New Zealand’s (USANZ) annual trainee week in the beautiful city of Adelaide, South Australia. Each year, USANZ organises a week for their local...

Emphysematous pyelonephritis: a review

1 May 2014 | | URO - Endourology & Stones, URO - Infection
Introduction Emphysematous pyelonephritis (EPN) is an acute, severe, necrotising, bacterial infection of the renal parenchyma and surrounding tissues, with gas in the renal parenchyma, collecting system or perinephric tissue. Although it is rare, it is potentially life threatening and early...

Patient portals

1 May 2014 | | URO - Technology
In May 2012, the Department of Health published its information strategy ‘Power of information’ which aims to put us all in control of the health and care information we need [1]. As a part of its information strategy a key...

Blaedderwaerc and other names

1 July 2016 | | URO - Infection, URO - Functional / Reconstructive Urology, URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In the last article I said I would explore the history of something...

Urolithiasis – metabolic considerations

5 January 2022 | | URO - Endourology & Stones
Case 1 A 32-year-old female patient is diagnosed with a ureteric calculus for the first-time. What type of metabolic evaluation investigations should be performed? When should stone analysis be repeated? What are the most common metabolic abnormalities associated with calcium...

Dietary citrate substitution in urolithiasis patients

1 July 2018 | | URO - Endourology & Stones
Stone formation is dependent on supersaturation of urinary salts and urinary crystal retention. Urinary promoters (protein aggregates, cell debris) and inhibitors (citrate, magnesium, urinary macromolecules such as glycosaminoglycans and proteins) are involved in the process of stone formation [1]. Hypocitraturia...

Current developments and innovations of the WASHOUT study: A large-scale observational study of inpatient haematuria

8 January 2025 | | URO - Trauma & Emergency, URO - Functional / Reconstructive Urology, URO - Infection
Unscheduled haematuria admissions ranks among the most common urological emergencies, yet its investigation and management still lack standardisation. The readmission rate for haematuria is substantial, with reports as high as 8%, and the median hospital stay for such cases in...

ICS (International Continence Society) 2024

23 October 2024 -25 October 2024
Each year, the International Continence Society hosts its annual meeting bringing together healthcare professionals interested in treating incontinence patients. Attendees can benefit from the latest research, professional development and networking opportunities. It provides a platform to exchange ideas and share best practices. Leading experts in the field also present workshops and state of the art sessions.